Skip to Main Content

Rise and shine, everyone, another busy day is on the way. We can tell by the usual barometers on the Pharmalot campus — our short person is hunched over a laptop for another day of learning and the official mascot is outside barking at passing birds. And there are a lot of them. This means, however, that we are free to brew another cup of stimulation. Our choice today is … maple bourbon. As always, feel free to join us. Meanwhile, here are a few items of interest. We hope your day is productive and, of course, safe — remember to wear that mask. …

U.S. health officials say that results from a trial of the AstraZeneca (AZN) Covid-19 vaccine may have included “outdated information” and that could mean the company provided an incomplete view of efficacy data, STAT reports. The company reported on Monday that its vaccine provided strong protection among adults of all ages in a long-anticipated study, a finding that some experts hoped would help rebuild public confidence in the shot around the world and move it a step closer to clearance in the U.S.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!